| 000 | 01850 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517004306.0 | ||
| 264 | 0 | _c20151124 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/j.bbamem.2014.10.036 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuéguinou, Maxime | |
| 245 | 0 | 0 |
_aLipid rafts, KCa/ClCa/Ca2+ channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids? _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cOct 2015 |
||
| 300 |
_a2603-20 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium Channels _xgenetics |
| 650 | 0 | 4 |
_aChloride Channels _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aFatty Acids, Omega-3 _xtherapeutic use |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsoenzymes _xgenetics |
| 650 | 0 | 4 |
_aLinoleic Acids, Conjugated _xtherapeutic use |
| 650 | 0 | 4 |
_aMembrane Lipids _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMembrane Microdomains _xdrug effects |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPotassium Channels _xgenetics |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aGambade, Audrey | |
| 700 | 1 | _aFélix, Romain | |
| 700 | 1 | _aChantôme, Aurélie | |
| 700 | 1 | _aFourbon, Yann | |
| 700 | 1 | _aBougnoux, Philippe | |
| 700 | 1 | _aWeber, Günther | |
| 700 | 1 | _aPotier-Cartereau, Marie | |
| 700 | 1 | _aVandier, Christophe | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 1848 _gno. 10 Pt B _gp. 2603-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbamem.2014.10.036 _zAvailable from publisher's website |
| 999 |
_c24404902 _d24404902 |
||